Skip to main content
WeightCited

Alpha-Lipoic Acid ： Insulin Resistance

B

Alpha-lipoic acid activates AMPK in multiple tissues. RCTs demonstrate improved insulin sensitivity in type 2 diabetics. It is approved in Germany for diabetic neuropathy at 600 mg/day. Both fat- and water-soluble, it reaches all tissue compartments.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dalpha\u002Dlipoic\u002Dacid\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
結論

            
            
Alpha-lipoic acid activates AMPK in multiple tissues. RCTs demonstrate improved insulin sensitivity in type 2 diabetics. It is approved in Germany for diabetic neuropathy at 600 mg/day. Both fat- and water-soluble, it reaches all tissue compartments.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
10

        
研究数

    

    

        
800

        
参加者数

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
グレード

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
一般的な使用量

                

                    
                    

                        
general:

                        
300-600 mg/day

                    

                    
                    

                        
ralaactiveform:

                        
150-300 mg/day

                    

                    
                    

                        
weightmanagement:

                        
600-1,800 mg/day

                    

                    
                

                
                

                    上限量： 1,800 mg/day; GI side effects at higher doses
                

                
            

            

            

            
            

                推奨摂取タイミング： 30 minutes before meals on empty stomach (food reduces absorption by ~30%)
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
報告されている副作用

                    
    
                        
                        
  • 
                            ⚠
                            Nausea
                        
    • 
                        
                        
  • 
                            ⚠
                            Skin rash
                        
    • 
                        
                        
  • 
                            ⚠
                            Hypoglycemia (when combined with diabetes medications)
                        
    • 
                        
                        
  • 
                            ⚠
                            GI discomfort
                        
    • 
                        
                    

                

                

                
                

                    
既知の相互作用

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may potentiate — hypoglycemia risk)
                        
    • 
                        
                        
  • 
                            ●
                            Thyroid medications (may affect thyroid hormone levels)
                        
    • 
                        
                        
  • 
                            ●
                            Chemotherapy agents (antioxidant interaction)
                        
    • 
                        
                    

                

                

                
                

                    

                        耐容上限摂取量： 1,800 mg/day; GI side effects at higher doses
                    

                

                
            

            

                サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Alpha-Lipoic Acid help with Insulin Resistance?
            
        
        

            Based on 10 studies with 800 participants, there is moderate evidence from clinical studies that Alpha-Lipoic Acid may support Insulin Resistance management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Alpha-Lipoic Acid should I take for Insulin Resistance?
            
        
        

            Studies have used various dosages. A commonly studied range is 300-600 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Alpha-Lipoic Acid?
            
        
        

            Reported side effects may include Nausea, Skin rash, Hypoglycemia (when combined with diabetes medications), GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Alpha-Lipoic Acid and Insulin Resistance?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
Alpha-Lipoic Acid 他の症状・状態について

                    

                        
                        
                            Obesity
                            B

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。